Wei Dong Jiang
Founder en SHANGHAI HENLIUS BIOTECH, INC. .
Fortuna: 1 M $ al 31/03/2024
Cargos activos de Wei Dong Jiang
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
SHANGHAI HENLIUS BIOTECH, INC. | Chief Tech/Sci/R&D Officer | 01/12/2009 | - |
Founder | 01/12/2009 | - |
Historial de carrera de Wei Dong Jiang
Antiguos cargos conocidos de Wei Dong Jiang.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Henlius Biopharmaceuticals, Inc.
Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Henlius Biopharmaceuticals, Inc. focuses on development and commercialization of mAb-based therapeutics biosimilars and biobetter for malignant tumors and auto-immune diseases. The company was founded by Scott Liu and Paul Liu in 2009 and is headquartered in Fremont, CA. | Chief Tech/Sci/R&D Officer | 01/01/2009 | - |
Founder | 01/01/2009 | - |
Formación de Wei Dong Jiang.
University of Giessen | Doctorate Degree |
Zhejiang University | Undergraduate Degree |
Estadísticas
Internacional
China | 3 |
Alemania | 2 |
Estados Unidos | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
Undergraduate Degree | 1 |
Sectorial
Consumer Services | 3 |
Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
SHANGHAI HENLIUS BIOTECH, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Henlius Biopharmaceuticals, Inc.
Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Henlius Biopharmaceuticals, Inc. focuses on development and commercialization of mAb-based therapeutics biosimilars and biobetter for malignant tumors and auto-immune diseases. The company was founded by Scott Liu and Paul Liu in 2009 and is headquartered in Fremont, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Wei Dong Jiang
- Experiencia